![Richard Hawkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Hawkins
Président chez
PLUS THERAPEUTICS, INC.
Fortune : 634 492 $ au 31/05/2026
Profil
Richard J.
Hawkins was the founder of Pharmaco, founded in 1982, serving as Chairman, President & Chief Executive Officer until 2000.
Founder of id2, Inc, founded in 1992, serving as President & Chief Executive Officer.
Founder of Sensus Drug Development Corp., founded in 1992, serving as Chairman until 2001.
Founder of Diosynth RTP, Inc., founded in 1994, serving as Director from 1994 to 2000.
Founder of Covance Biotechnology Services, Inc., founded in 1995, serving as Director.
Founder of LabNow, Inc., founded in 2003, serving as Chairman, President & Chief Executive Officer from 2003 to 2009.
Founder of Lumos Pharma Sub, Inc., founded in 2010, serving as President, Chief Executive Officer & Director from 2010 to 2020.
Founder of Entvantage Diagnostics, Inc., founded in 2014, serving as Chairman.
Current jobs include Chairman at Plus Therapeutics, Inc. since 2018, Independent Director at Savara, Inc. since 2010, Director at Cytori Therapeutics, Inc., and Operating Partner at Havencrest Capital Management LLC.
Former jobs include Chief Executive Officer & Director at NewLink Genetics Corp.
in 2020, Chairman & Chief Executive Officer at Lumos Pharma, Inc. from 2021 to 2024, Chairman at LoopOne, Inc., Independent Director at SciClone Pharmaceuticals LLC from 2004 to 2017, Director at Aravas, Inc., Director at Synexus Compass, Inc., Director at Entvantage Diagnostic Associates LLC, Board member at Aravas, Inc., and General Partner at Dominion Ventures, Inc.Education includes undergraduate degree from The Ohio University, conferred in 1972.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAVARA, INC. 0,06 % | 06/04/2026 | 121 326 ( 0,06 % ) | 630 895 $ | 31/05/2026 |
PLUS THERAPEUTICS, INC. 0,01 % | 14/05/2026 | 608 ( 0,01 % ) | 3 539 $ | 31/05/2026 |
| 25/07/2018 | 10 ( -.--% ) | 58 $ | 31/05/2026 |
Postes actifs de Richard Hawkins
| Sociétés | Poste | Début |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Président | 25/01/2018 |
| SAVARA INC. | Directeur/Membre du Conseil | 01/10/2010 |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital invests in lower-middle market companies located in the United States with an EBITDA of USD 3 - 15 million and enterprise value of USD 25 - 250 million. The firm focuses on a broad range of sectors and industries. It participates in add on acquisitions, buyouts, recapitalization and growth stage capital transactions. It acquires controlling and non controlling stakes. | Private Equity Investor | - |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Directeur/Membre du Conseil | - |
Entvantage Diagnostics, Inc.
 Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic test kits | Fondateur | 01/01/2014 |
id2, Inc
 id2, Inc Information Technology ServicesTechnology Services Provides custom computer programming services | Directeur Général | 01/01/1992 |
Anciens postes connus de Richard Hawkins
| Sociétés | Poste | Fin |
|---|---|---|
| LUMOS PHARMA, INC. | Directeur Général | 01/12/2024 |
Entvantage Diagnostic Associates LLC
 Entvantage Diagnostic Associates LLC BiotechnologyHealth Technology Operates as biotechnology company | Directeur/Membre du Conseil | 12/09/2022 |
| SCICLONE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/12/2017 |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard Hawkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Sensus Drug Development Corp.
 Sensus Drug Development Corp. Pharmaceuticals: OtherHealth Technology Develops drugs to treat endocrine disorders | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
LabNow, Inc.
 LabNow, Inc. Medical SpecialtiesHealth Technology Manufactures sensor technology systems | Health Technology |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative drugs for the treatment of serious and life-threatening conditions | Health Technology |
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Provides medical image analysis, subject recruitment and biochemical marker services | Health Services |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Diosynth RTP, Inc.
 Diosynth RTP, Inc. BiotechnologyHealth Technology Provides current good manufacturing practices and pharmaceutical products | Health Technology |
Dominion Ventures, Inc.
 Dominion Ventures, Inc. Investment ManagersFinance Dominion Ventures invests in emerging technology companies located in the US. The firm targets companies operating in the fields of Communications, Software and Services. It acquires minority stakes & provides financing for growth stage capital requirements. It acts as lead investor with an investment size ranging from $3 to $10 million and an initial investment size of $2 - $4 million. Dominion Ventures takes a seat on the board of directors and also considers co-investments. | Finance |
id2, Inc
id2, Inc Information Technology ServicesTechnology Services Provides custom computer programming services | Technology Services |
LoopOne, Inc. | |
Pharmaco
 Pharmaco Drugstore ChainsRetail Trade Acquires, develops, and markets niche pharmaceutical products | Retail Trade |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Entvantage Diagnostics, Inc.
Entvantage Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic test kits | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital invests in lower-middle market companies located in the United States with an EBITDA of USD 3 - 15 million and enterprise value of USD 25 - 250 million. The firm focuses on a broad range of sectors and industries. It participates in add on acquisitions, buyouts, recapitalization and growth stage capital transactions. It acquires controlling and non controlling stakes. | Finance |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Health Technology |
Entvantage Diagnostic Associates LLC
Entvantage Diagnostic Associates LLC BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
